Cannabis stocks fall as Florida rejects legalization of recreational marijuana
David Trood
U.S.-listed cannabis stocks slipped in premarket trading on Wednesday after a costly campaign to legalize recreational marijuana in Florida failed late Tuesday.
The approval of Amendment 3 would have given way for medical cannabis dispensaries and other licensed state entities to sell cannabis products to consumers 21 years of age and older.
Shares of Tilray Brands (NASDAQ:TLRY) down 10%, SNDL (NASDAQ:SNDL), Cronos Group (NASDAQ:CRON) fell 18% and 4%, respectively.
Canopy Growth (NASDAQ:CGC) was down over 20% and Aurora Cannabis (NASDAQ:ACB) dropped 9%. AdvisorShares Pure US Cannabis ETF (MSOS) dropped 13%.
The initiative's rejection is considered a victory for Gov. Ron DeSantis (Rep.), who had campaigned against it. Donald Trump, elected the 47th President of the United States, and a Florida resident, has said he favored the measure.
In the past, Trump has stated his support for leaving recreational cannabis legalization up to individual states.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10